About 2 results found for searched term "Mobocertinib" (0.49 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M9535 | Mobocertinib | EGFR/HER2 |
| TAK-788; AP32788 | ||
| Mobocertinib (TAK-788) is an investigational TKI with potent, selective preclinical activity against activating EGFR and HER2 mutations, including exon 20 insertions. | ||
| M14138 | Mobocertinib succinate | EGFR/HER2 |
| TAK-788 succinate; AP32788 succinate | ||
| Mobocertinib succinate (TAK-788 succinate) is a potent and orally active inhibitor of EGFR and HER2 oncogenic mutants, including exon 20 insertions, with selectivity over WT EGFR. Antitumor activity. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.
